118 related articles for article (PubMed ID: 38379131)
1. Optimized Design of Hyaluronic Acid-Lipid Conjugate Biomaterial for Augmenting CD44 Recognition of Surface-Engineered NK Cells.
Park HW; Lee W; Kim S; Jangid AK; Park J; Lee CE; Kim K
Biomacromolecules; 2024 Mar; 25(3):1959-1971. PubMed ID: 38379131
[TBL] [Abstract][Full Text] [Related]
2. Surface Engineering of Natural Killer Cells with CD44-targeting Ligands for Augmented Cancer Immunotherapy.
Kim S; Li S; Jangid AK; Park HW; Lee DJ; Jung HS; Kim K
Small; 2024 Jun; 20(24):e2306738. PubMed ID: 38161257
[TBL] [Abstract][Full Text] [Related]
3. Tailoring tumor-recognizable hyaluronic acid-lipid conjugates to enhance anticancer efficacies of surface-engineered natural killer cells.
Lee CE; Kim S; Park HW; Lee W; Jangid AK; Choi Y; Jeong WJ; Kim K
Nano Converg; 2023 Dec; 10(1):56. PubMed ID: 38097911
[TBL] [Abstract][Full Text] [Related]
4. Biomaterial-Mediated Exogenous Facile Coating of Natural Killer Cells for Enhancing Anticancer Efficacy toward Hepatocellular Carcinoma.
Jangid AK; Kim S; Kim HJ; Kim K
Bioconjug Chem; 2023 Oct; 34(10):1789-1801. PubMed ID: 37726892
[TBL] [Abstract][Full Text] [Related]
5. Hyaluronan polymer length, grafting density, and surface poly(ethylene glycol) coating influence in vivo circulation and tumor targeting of hyaluronan-grafted liposomes.
Qhattal HS; Hye T; Alali A; Liu X
ACS Nano; 2014 Jun; 8(6):5423-40. PubMed ID: 24806526
[TBL] [Abstract][Full Text] [Related]
6. Hyaluronic acid-coated pH sensitive poly (β-amino ester) nanoparticles for co-delivery of embelin and TRAIL plasmid for triple negative breast cancer treatment.
Xu Y; Liu D; Hu J; Ding P; Chen M
Int J Pharm; 2020 Jan; 573():118637. PubMed ID: 31550511
[TBL] [Abstract][Full Text] [Related]
7. Lipid-mediated ex vivo cell surface engineering for augmented cellular functionalities.
Kim S; Kim K
Biomater Adv; 2022 Sep; 140():213059. PubMed ID: 35961186
[TBL] [Abstract][Full Text] [Related]
8. Ex Vivo Surface Decoration of Phenylboronic Acid onto Natural Killer Cells for Sialic Acid-Mediated Versatile Cancer Cell Targeting.
Jangid AK; Kim S; Park HW; Kim HJ; Kim K
Biomacromolecules; 2024 Jan; 25(1):222-237. PubMed ID: 38130077
[TBL] [Abstract][Full Text] [Related]
9. Hyaluronic acid-serum albumin conjugate-based nanoparticles for targeted cancer therapy.
Edelman R; Assaraf YG; Levitzky I; Shahar T; Livney YD
Oncotarget; 2017 Apr; 8(15):24337-24353. PubMed ID: 28212584
[TBL] [Abstract][Full Text] [Related]
10. CD44 directed nanomicellar payload delivery platform for selective anticancer effect and tumor specific imaging of triple negative breast cancer.
Wang Z; Sau S; Alsaab HO; Iyer AK
Nanomedicine; 2018 Jun; 14(4):1441-1454. PubMed ID: 29678787
[TBL] [Abstract][Full Text] [Related]
11. Anticancer Analysis of CD44 Targeted Cyclosporine Loaded Thiolated Chitosan Nanoformulations for Sustained Release in Triple-Negative Breast Cancer.
Abduh MS
Int J Nanomedicine; 2023; 18():5713-5732. PubMed ID: 37849642
[TBL] [Abstract][Full Text] [Related]
12. Co-delivery of gambogic acid and TRAIL plasmid by hyaluronic acid grafted PEI-PLGA nanoparticles for the treatment of triple negative breast cancer.
Wang S; Shao M; Zhong Z; Wang A; Cao J; Lu Y; Wang Y; Zhang J
Drug Deliv; 2017 Nov; 24(1):1791-1800. PubMed ID: 29172759
[TBL] [Abstract][Full Text] [Related]
13. Combinational siRNA delivery using hyaluronic acid modified amphiphilic polyplexes against cell cycle and phosphatase proteins to inhibit growth and migration of triple-negative breast cancer cells.
Parmar MB; Meenakshi Sundaram DN; K C RB; Maranchuk R; Montazeri Aliabadi H; Hugh JC; Löbenberg R; Uludağ H
Acta Biomater; 2018 Jan; 66():294-309. PubMed ID: 29183848
[TBL] [Abstract][Full Text] [Related]
14. Hyaluronic acid based self-assembling nanosystems for CD44 target mediated siRNA delivery to solid tumors.
Ganesh S; Iyer AK; Morrissey DV; Amiji MM
Biomaterials; 2013 Apr; 34(13):3489-502. PubMed ID: 23410679
[TBL] [Abstract][Full Text] [Related]
15. Hyaluronic acid-based nanogel-drug conjugates with enhanced anticancer activity designed for the targeting of CD44-positive and drug-resistant tumors.
Wei X; Senanayake TH; Warren G; Vinogradov SV
Bioconjug Chem; 2013 Apr; 24(4):658-68. PubMed ID: 23547842
[TBL] [Abstract][Full Text] [Related]
16. Hyaluronic acid engrafted metformin loaded graphene oxide nanoparticle as CD44 targeted anti-cancer therapy for triple negative breast cancer.
Basu A; Upadhyay P; Ghosh A; Bose A; Gupta P; Chattopadhyay S; Chattopadhyay D; Adhikary A
Biochim Biophys Acta Gen Subj; 2021 Mar; 1865(3):129841. PubMed ID: 33412224
[TBL] [Abstract][Full Text] [Related]
17. Hyaluronic acid-nimesulide conjugates as anticancer drugs against CD44-overexpressing HT-29 colorectal cancer in vitro and in vivo.
Jian YS; Chen CW; Lin CA; Yu HP; Lin HY; Liao MY; Wu SH; Lin YF; Lai PS
Int J Nanomedicine; 2017; 12():2315-2333. PubMed ID: 28392690
[TBL] [Abstract][Full Text] [Related]
18. Targeted immunotherapy of triple-negative breast cancer by aptamer-engineered NK cells.
Chen Z; Zeng Z; Wan Q; Liu X; Qi J; Zu Y
Biomaterials; 2022 Jan; 280():121259. PubMed ID: 34801254
[TBL] [Abstract][Full Text] [Related]
19. Hyaluronic-Acid-Tagged Cubosomes Deliver Cytotoxics Specifically to CD44-Positive Cancer Cells.
Pramanik A; Xu Z; Ingram N; Coletta PL; Millner PA; Tyler AII; Hughes TA
Mol Pharm; 2022 Dec; 19(12):4601-4611. PubMed ID: 35938983
[TBL] [Abstract][Full Text] [Related]
20. Engineered Metal-Phenolic Capsules Show Tunable Targeted Delivery to Cancer Cells.
Ju Y; Cui J; Sun H; Müllner M; Dai Y; Guo J; Bertleff-Zieschang N; Suma T; Richardson JJ; Caruso F
Biomacromolecules; 2016 Jun; 17(6):2268-76. PubMed ID: 27249228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
